The landscape of ROS1 fusion in patients with non-small cell lung cancer in China

被引：0
作者：
Chen, M. [1 ]
Huang, D. [2 ]
She, X. [2 ]
Shen, X. [2 ]
Zhang, H. [2 ]
Luo, Z. [3 ]
机构：
[1] Chongqing Med Univ, Affiliated Hosp 3, Dept Resp, Chongqing, Peoples R China
[2] 3D Med Inc, Dept Med, Shanghai, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 3, Dept Thorac Surg, Chongqing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1722
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1408P
引用
收藏
页码：S891 / S891
页数：1
相关论文
共 50 条
[41]   ROS1 fusions in Chinese patients with non-small-cell lung cancer [J].
Cai, W. ;
Li, X. ;
Su, C. ;
Fan, L. ;
Zheng, L. ;
Fei, K. ;
Zhou, C. ;
Manegold, C. ;
Schmid-Bindert, G. .
ANNALS OF ONCOLOGY, 2013, 24 (07) :1822-1827
[42]   ROS1 gene rearrangement and copy number gain in non-small cell lung cancer [J].
Yan Jin ;
Ping-Li Sun ;
Hyojin Kim ;
Eunhyang Park ;
Hyo Sup Shim ;
Sanghoon Jheon ;
Kwhanmien Kim ;
Choon-Taek Lee ;
Jin-Haeng Chung .
Virchows Archiv, 2015, 466 :45-52
[43]   ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers [J].
Roskoski, Robert, Jr. .
PHARMACOLOGICAL RESEARCH, 2017, 121 :202-212
[44]   The fusion gene landscape in Chinese patients with non-small cell lung cancer [J].
Lin, Qiuju ;
Fu, Zhichao .
CANCER RESEARCH, 2022, 82 (12)
[45]   The Fusion Gene Landscape in Taiwanese Patients with Non-Small Cell Lung Cancer [J].
Chang, Ya-Sian ;
Tu, Siang-Jyun ;
Yen, Ju-Chen ;
Lee, Ya-Ting ;
Fang, Hsin-Yuan ;
Chang, Jan-Gowth .
CANCERS, 2021, 13 (06) :1-13
[46]   Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants [J].
Ohishi, Yuta ;
Nakanishi, Yoko ;
Hirotani, Yukari ;
Suzuki, Atsuko ;
Tanino, Tomoyuki ;
Nishimaki-Watanabe, Haruna ;
Kobayashi, Hiroko ;
Nozaki, Fumi ;
Ohni, Sumie ;
Tang, Xiaoyan ;
Hayashi, Kentaro ;
Nakagawa, Yoshiko ;
Shimizu, Tetsuo ;
Tsujino, Ichiro ;
Takahashi, Noriaki ;
Gon, Yasuhiro ;
Masuda, Shinobu .
THORACIC CANCER, 2024, 15 (01) :89-93
[47]   Appearance of a BRAF Mutation Conferring Resistance to Crizotinib in Non-Small Cell Lung Cancer Harboring Oncogenic ROS1 Fusion [J].
Watanabe, Junko ;
Furuya, Naoki ;
Fujiwara, Yutaka .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) :E66-E69
[48]   Clinical Validation of a Real Time PCR Assay for the Detection of ROS1 Fusion in Chinese Non-Small Cell Lung Cancer [J].
Zhu, G. ;
Huang, G. ;
Song, Q. .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S2244-S2245
[49]   Appearance of an ALK mutation conferring resistance to crizotinib in non-small cell lung cancer harboring oncogenic ROS1 fusion [J].
Li, ZhiFeng ;
Lin, Yingcheng ;
Chi, Xiuying ;
Xu, Mian ;
Wang, Hongbiao .
LUNG CANCER, 2021, 153 :174-175
[50]   Survival and Therapy Analysis of Non-small cell lung cancer (NSCLC) patients with small-scale ROS1 Mutations [J].
Glaser, M. ;
Braegelmann, J. ;
Rasokat, A. ;
Nogova, L. ;
Woempner, C. ;
Schmitz, J. ;
Bitter, E. ;
Terjung, I ;
Eisert, A. ;
Fischer, R. ;
John, F. ;
Michels, S. ;
Riedel, R. ;
Ruge, L. ;
Scharpenseel, H. ;
Siebolts, U. ;
Merkelbach-Bruse, S. ;
Buettner, R. ;
Wolf, J. ;
Scheffler, M. .
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 :10-10
12345